Alliance NCORP Research Base
Alliance NCORP Research Base
批准号:
10908061
负责人:
Suzanne George
金额:
$59.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2025-07-31
关键词:
Academic Medical CentersAddressAdvocateAgingAreaAttentionBehaviorBloodCancer BurdenCancer PatientCancer Research ProjectCaregiversClinicalClinical OncologyClinical ResearchClinical TrialsCollaborationsCollectionCommittee MembershipCommunitiesCommunity Clinical Oncology ProgramCompanionsDataData ReportingDatabasesDevelopmentDiagnosisDiseaseDisparityEarly DiagnosisEducationElderlyFunctional disorderFundingFunding OpportunitiesGrantHealthHumanIncidenceInterventionMaintenanceMalignant NeoplasmsManuscriptsMentorsMentorshipMetastatic Neoplasm to the BoneMetastatic malignant neoplasm to brainMinorityMinority GroupsMissionMonitorMorbidity - disease rateNational Cancer InstituteNational Clinical Trials NetworkNatural HistoryNausea and VomitingOncologistOncologyOutcomeOutcome AssessmentOutcomes ResearchParentsPatient Outcomes AssessmentsPatientsPharmacologic SubstancePopulationPrevalencePreventionPublishingQuality of lifeResearchResearch MethodologyResearch PersonnelResearch PriorityRiskSiteSourceSymptomsTechnologyTissue SampleToxic effectTrainingTranslational ResearchTumor TissueUnderserved PopulationUnited StatesWorkbasecancer carecancer clinical trialcancer health disparitycancer preventioncancer riskcancer therapycare deliverychemotherapyclinically relevantclinically significantcommunity engagementcurative treatmentsdata sharingdisparity eliminationdisparity reductionexperiencefinancial toxicityforginghealth disparityhigh riskimprovedinnovationmortalitymultidisciplinarynext generationnovelolder patientpremalignantpreventprogramsreduce symptomsrepositoryskeletal-related eventssurvivorshiptranslational oncologytreatment trialunderserved community
中文摘要
联盟NCORP研究基地
项目摘要/摘要
肿瘤学临床试验联盟(联盟),五个国家临床试验网络组织之一,
作为联盟NCI社区肿瘤学研究计划(NCORP)的上级组织
研究基地(NCORP联盟)。NCORP联盟进行临床干预和观察性研究
和翻译研究以及数据库研究-所有这些研究都解决了与以下方面相关的重要问题
癌症预防、症状控制和癌症护理服务。此外,NCORP联盟还进行
嵌入癌症治疗试验的具有临床重要性的生活质量研究。它把特别的地方
强调少数群体、服务不足和老年患者有患癌症的风险或被诊断为癌症,并建立
与NCORP社区站点和少数族裔/未得到充分服务的社区站点建立牢固的合作关系。这个
联盟NCORP委员会成员包括来自社区和
学术医学中心以及患者权益倡导者,从而产生与癌症相关的研究结果
美国各地的患者。NCORP联盟还强调对青少年的指导和培训
调查人员。在过去的赠款周期中,也就是自2014年8月以来,NCORP联盟发布了148份
手稿和摘要。这项工作包括在以下领域的实践改变研究
预防化疗引起的恶心和呕吐,预防与骨骼有关的事件
骨转移、脑转移的处理和患者报告结果的整合
进入癌症临床试验。联盟NCORP进行翻译研究,需要收集
肿瘤组织、癌前组织样本、血液和其他人类生物标本;并共享数据和
用于集中分析和其他科学合作的生物检疫剂。这些生物标本创造了一种
从机械论的角度理解临床观察的无价之宝。《联盟》
NCORP还与NCI资助的其他调查人员和财团以及
调查人员通过非NCI来源提供支持。这种改变实践的研究和科学
联盟NCORP回答的问题为临床和治疗提供了有意义的创新贡献
翻译肿瘤学,只能在公共资助的研究网络中进行。
英文摘要
Alliance NCORP Research Base
Project Summary/Abstract
The Alliance for Clinical Trials in Oncology (Alliance), one of five National Clinical Trials Network groups,
serves as the parent organization for the Alliance NCI Community Oncology Research Program (NCORP)
Research Base (Alliance NCORP). The Alliance NCORP conducts interventional and observational clinical
and translational research as well as database studies – all of which address important questions relevant to
cancer prevention, symptom control, and cancer care delivery. In addition, the Alliance NCORP conducts
clinically important quality of life studies that are embedded within cancer treatment trials. It places special
emphasis on minority, underserved and older patients at risk for or diagnosed with cancer, and on building
strong collegial relationships with NCORP Community sites and Minority/Underserved Community sites. The
Alliance NCORP committee membership includes rich representation from both community-based and
academic medical centers, as well as patient advocates, thus generating research results relevant to cancer
patients across the United States. The Alliance NCORP also emphasizes mentorship and training of junior
investigators. Over this past grant cycle, i.e., since August 2014, the Alliance NCORP has published 148
manuscripts and abstracts. This work has included practice-changing research in such areas as the
prevention of chemotherapy-induced nausea and vomiting, the prevention of skeletal-related events from
osseous metastases, the management of brain metastases, and the integration of patient-reported outcomes
into cancer clinical trials. The Alliance NCORP conducts translational research that requires the collection of
tumor tissue, premalignant tissue samples, blood, and other human biospecimens; and shares data and
biospecimens for pooled analyses and other scientific collaborations. These biospecimens create an
invaluable repository for understanding clinical observations from a mechanistic standpoint. The Alliance
NCORP also collaborates broadly with other NCI-funded investigators and consortia, as well as with
investigators supported through non-NCI sources. This practice-changing research and the scientific
questions answered by the Alliance NCORP provide meaningful and innovative contributions to clinical and
translational oncology, which can be conducted only within a publicly-funded research network.
期刊论文(66)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Patient Experience, Adverse Event Reporting, and Clinical Trial Design.
患者体验、不良事件报告和临床试验设计。
DOI:
10.1200/jco.23.01976
发表时间:
2024
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
[Neuman,HeatherB]
通讯作者:
Neuman,HeatherB
DOI:
10.1016/j.jss.2018.02.053
发表时间:
2018-07
期刊:
The Journal of surgical research
影响因子:
--
作者:
[In H, Langdon-Embry M, Gordon L, Schechter CB, Wylie-Rosett J, Castle PE, Margaret Kemeny M, Rapkin BD]
通讯作者:
Rapkin BD
DOI:
10.1186/s12885-023-10919-x
发表时间:
2023-06-10
期刊:
BMC CANCER
影响因子:
3.8
作者:
[Xu, Shenmeng, Tan, Xianming, Ma, Chunxuan, McElyea, Rebecca S. S., Shieh, Karl, Stover, Angela M. M., Smith, Angela, Stitzenberg, Karyn, Basch, Ethan, Song, Lixin]
通讯作者:
Song, Lixin
DOI:
10.1001/jamaoncol.2015.2639
发表时间:
2015-11
期刊:
JAMA oncology
影响因子:
28.4
作者:
[Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E, National Cancer Institute PRO-CTCAE Study Group]
通讯作者:
National Cancer Institute PRO-CTCAE Study Group
DOI:
10.1007/s00520-016-3080-y
发表时间:
2016-06
期刊:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
影响因子:
--
作者:
[Kottschade L, Novotny P, Lyss A, Mazurczak M, Loprinzi C, Barton D]
通讯作者:
Barton D
共 34 条
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
-
批准号:10703401
-
项目类别:
-
资助金额:$184.94万
-
财政年份:2020
-
负责人:Suzanne George
-
依托单位:
Alliance for Clinical Trials in Oncology Operations Center
-
批准号:10669309
-
项目类别:
-
资助金额:$122.2万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance for Clinical Trials in Oncology Operations Center
-
批准号:10361387
-
项目类别:
-
资助金额:$864.38万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance Grant Year 9 BIQSFP Supplements
-
批准号:10542466
-
项目类别:
-
资助金额:$240.88万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance for Clinical Trials in Oncology Operations Center - GY10 irAE A151804 Administrative Supplement
-
批准号:10755545
-
项目类别:
-
资助金额:$152.91万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance Grant Year 9 Administrative Supplements
-
批准号:10542289
-
项目类别:
-
资助金额:$140.0万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance NCORP Research Base - BIQSFP GY10 Supplements
-
批准号:10850323
-
项目类别:
-
资助金额:$40.66万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance NCORP Research Base
-
批准号:10688630
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance for Clinical Trials in Oncology Operations Center - GY9 NCCAPS Additional Capitation
-
批准号:10738475
-
项目类别:
-
资助金额:$81.77万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
Alliance for Clinical Trials in Oncology Operations Center - GY10 BIQSFP Supplement
-
批准号:10755524
-
项目类别:
-
资助金额:$282.46万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
A-STOR Cancer Clinical Trial Artificial Intelligence & Machine Learning Readiness
-
批准号:10593808
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2014
-
负责人:Suzanne George
-
依托单位:
海外基金